Company / Accounts Receivable
MIMEDX GROUP, INC. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$75.7M
FY2025
5-year range
$40.4M / $75.7M
FY2021-FY2025
Trend
+35.6%
vs FY2024
Sector context
#108 of 138
Health Care
What the data says
MIMEDX GROUP, INC.'s accounts receivable of $76M is lower than 78% of companies in the Health Care sector (FY2025). Accounts Receivable has increased for 6 consecutive years, from $32M in FY2019 to $76M in FY2025.
Based on SEC 10-K filings.
$76M in FY2025 with a 5-year CAGR of +16.4%.
Improved from $54M to $76M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +20.7%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 138This company $75.7M Sector average $1.4B
▼
-94.5% below sector average
Key checks
Key Insights
- MIMEDX GROUP, INC.'s accounts receivable has grown for 6 consecutive years.
- 5-year CAGR of +16.4%, indicating consistent growth.
- In FY2025, accounts receivable increased 35.6% year-over-year.
- Ranks #108 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.7M | +35.6% |
| FY2024 | $55.8M | +3.6% |
| FY2023 | $53.9M | +25.0% |
| FY2022 | $43.1M | +6.8% |
| FY2021 | $40.4M | +13.9% |
| FY2020 | $35.4M | +9.6% |
| FY2019 | $32.3M | -36.6% |
| FY2018 | $51.0M | -21.3% |
| FY2017 | $64.8M | +3262.7% |
| FY2016 | $1.9M | -96.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026